Reviewing BeyondAirInc . (XAIR) & The Competition

Share on StockTwits

BeyondAirInc . (NASDAQ: XAIR) is one of 128 public companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare BeyondAirInc . to related businesses based on the strength of its dividends, risk, valuation, institutional ownership, earnings, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for BeyondAirInc . and its rivals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BeyondAirInc . 0 0 0 0 N/A
BeyondAirInc . Competitors 954 3193 5404 288 2.51

As a group, “Surgical & medical instruments” companies have a potential upside of 19.07%. Given BeyondAirInc .’s rivals higher possible upside, analysts plainly believe BeyondAirInc . has less favorable growth aspects than its rivals.

Valuation & Earnings

This table compares BeyondAirInc . and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
BeyondAirInc . $7.72 million -$6.56 million -5.81
BeyondAirInc . Competitors $1.41 billion $143.83 million -16.58

BeyondAirInc .’s rivals have higher revenue and earnings than BeyondAirInc .. BeyondAirInc . is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.


This table compares BeyondAirInc . and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BeyondAirInc . N/A -342.71% -100.90%
BeyondAirInc . Competitors -674.05% -624.80% -22.23%

Volatility & Risk

BeyondAirInc . has a beta of -0.25, meaning that its stock price is 125% less volatile than the S&P 500. Comparatively, BeyondAirInc .’s rivals have a beta of 0.99, meaning that their average stock price is 1% less volatile than the S&P 500.

Insider and Institutional Ownership

5.4% of BeyondAirInc . shares are held by institutional investors. Comparatively, 50.4% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 15.4% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.


BeyondAirInc . rivals beat BeyondAirInc . on 7 of the 10 factors compared.

About BeyondAirInc .

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.

Receive News & Ratings for BeyondAirInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondAirInc . and related companies with's FREE daily email newsletter.